[HTML][HTML] Inflammatory and metabolic signaling interfaces of the hypertrophic and senescent chondrocyte phenotypes associated with osteoarthritis
Osteoarthritis (OA) is a complex disease of whole joints with progressive cartilage matrix
degradation and chondrocyte transformation. The inflammatory features of OA are reflected …
degradation and chondrocyte transformation. The inflammatory features of OA are reflected …
Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings
G Hein, C Weiss, G Lehmann, T Niwa… - Annals of the …, 2006 - ard.bmj.com
Background: The process of bone remodelling is disturbed in the development of
osteoporosis. Objective: To investigate if proteins in osteoporotic bone are modified by …
osteoporosis. Objective: To investigate if proteins in osteoporotic bone are modified by …
Advanced glycation endproducts and osteoarthritis
DM Saudek, J Kay - Current rheumatology reports, 2003 - Springer
Non-enzymatic glycation of proteins, such as collagen, results in the formation of advanced
glycation endproducts (AGE). Advanced glycation endproducts result in pathologic stiffening …
glycation endproducts (AGE). Advanced glycation endproducts result in pathologic stiffening …
[HTML][HTML] RAGE and TGF-β1 cross-talk regulate extracellular matrix turnover and cytokine synthesis in AGEs exposed fibroblast cells
AGEs accumulation in the skin affects extracellular matrix (ECM) turnover and triggers
diabetes associated skin conditions and accelerated skin aging. The receptor of AGEs …
diabetes associated skin conditions and accelerated skin aging. The receptor of AGEs …
[HTML][HTML] Hyperglycemia-induced accumulation of advanced glycosylation end products in fibroblast-like synoviocytes promotes knee osteoarthritis
Q Li, Y Wen, L Wang, B Chen, J Chen… - … & Molecular Medicine, 2021 - nature.com
Osteoarthritis (OA) is significantly associated with diabetes, but how hyperglycemia induces
or aggravates OA has not been shown. The synovium plays a critical role in cartilage …
or aggravates OA has not been shown. The synovium plays a critical role in cartilage …
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses
Background—The products of nonenzymatic glycation and oxidation of proteins, the
advanced glycation end products (AGEs), form under diverse circumstances such as aging …
advanced glycation end products (AGEs), form under diverse circumstances such as aging …
Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells
Advanced glycation end products (AGEs) have been proposed as the pathological
mechanisms underlying diabetic chronic complications. They may also play a role in the …
mechanisms underlying diabetic chronic complications. They may also play a role in the …
[HTML][HTML] Aging-related inflammation in osteoarthritis
MA Greene, RF Loeser - Osteoarthritis and cartilage, 2015 - Elsevier
It is well accepted that aging is an important contributing factor to the development of
osteoarthritis (OA). The mechanisms responsible appear to be multifactorial and may …
osteoarthritis (OA). The mechanisms responsible appear to be multifactorial and may …
[HTML][HTML] Glycation of macrophages induces expression of pro-inflammatory cytokines and reduces phagocytic efficiency
V Bezold, P Rosenstock, J Scheffler, H Geyer… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Glycation and the accumulation of advanced glycation end products (AGEs) are known to
occur during normal aging but also in the progression of several diseases, such as diabetes …
occur during normal aging but also in the progression of several diseases, such as diabetes …
Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis
F Gao, S Zhang - Artificial Cells, Nanomedicine, and Biotechnology, 2019 - Taylor & Francis
Osteoarthritis (OA) is a major age-related disease, which may be caused by the
accumulation of advanced glycation end-products (AGEs). Excessive degradation of type II …
accumulation of advanced glycation end-products (AGEs). Excessive degradation of type II …